Do cognitive impairments limit treatment gains in a standalone digital intervention for psychosis? A test of the digital divide
Files
Accepted manuscript
Date
2022-06
Authors
Fulford, Daniel
Schupbach, Elizabeth
Gard, David E.
Mueser, Kim T.
Mow, Jessica
Leung, Lawrence
Version
Accepted manuscript
OA Version
Citation
D. Fulford, E. Schupbach, D.E. Gard, K.T. Mueser, J. Mow, L. Leung. 2022. "Do cognitive impairments limit treatment gains in a standalone digital intervention for psychosis? A test of the digital divide.." Schizophr Res Cogn, Volume 28, pp. 100244 - ?. https://doi.org/10.1016/j.scog.2022.100244
Abstract
Digital mental health interventions, such as those provided by smartphone applications (apps), show promise as cost-effective approaches to increasing access to evidence-based psychosocial interventions for psychosis. Although it is well known that limited financial resources can reduce the benefits of digital approaches to mental healthcare, the extent to which cognitive functioning in this population could impact capacity to engage in and benefit from these interventions is less studied. In the current study we examined the extent to which cognitive functioning (premorbid cognitive abilities and social cognition) were related to treatment engagement and outcome in a standalone digital intervention for social functioning. Premorbid cognitive abilities generally showed no association with aggregated treatment engagement markers, including proportion of notifications responded to and degree of interest in working on app content, though there was a small positive association with improvements in social functioning. Social cognition, as measured using facial affect recognition ability, was unrelated to treatment engagement or outcome. These preliminary findings suggest that cognitive functioning is generally not associated with engagement or outcomes in a standalone digital intervention designed for and with people with schizophrenia spectrum disorders.
Description
License
© 2022 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).